Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Satish K. Kedia, Nikhil Ahuja, Patrick J. Dillon, Andrew Jones, Santosh Kumar & Sanjaya Satapathy. (2023) Efficacy of Extended-Release Injectable Naltrexone on Alcohol Use Disorder Treatment: A Systematic Review. Journal of Psychoactive Drugs 55:2, pages 233-245.
Read now
Read now
M S Zastrozhin, V Yu Skryabin, S S Miroshkin, E A Bryun & D A Sychev. (2019) Pharmacogenetics of alcohol addiction: current perspectives. The Application of Clinical Genetics 12, pages 131-140.
Read now
Read now
Sarah J. Cousins, Loretta Denering, Desirée Crèvecoeur-MacPhail, John Viernes, Wayne Sugita, James Barger, Tina Kim, Stefanie Weimann & Richard A. Rawson. (2016) A demonstration project implementing extended-release naltrexone in Los Angeles County. Substance Abuse 37:1, pages 54-62.
Read now
Read now
Vanita R. Aroda & Mary Beth DeYoung. (2011) Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes. Postgraduate Medicine 123:5, pages 228-238.
Read now
Read now
Colin N. Haile, Therese A. Kosten & Thomas R. Kosten. (2008) Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates. The American Journal of Drug and Alcohol Abuse 34:4, pages 355-381.
Read now
Read now
Articles from other publishers (17)
Elyssa B. Margolis, Madelyn G. Moulton, Philip S. Lambeth & Matthew J. O'Meara. (2023) The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder. Neuropharmacology 225, pages 109376.
Crossref
Crossref
Sabrina Correa da Costa, Yara Moustafa, Adriana Vasquez & Teresa Rummans. 2023. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Matthew N. O'Brien, Wenlei Jiang, Yan Wang & David M. Loffredo. (2021) Challenges and opportunities in the development of complex generic long-acting injectable drug products. Journal of Controlled Release 336, pages 144-158.
Crossref
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide
537
540
.
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Falk W Lohoff. (2020) Pharmacotherapies and personalized medicine for alcohol use disorder: a review. Pharmacogenomics 21:15, pages 1117-1138.
Crossref
Crossref
Shannon Smith-Bernardin, Chris Rowe, Emily Behar, Michelle Geier, Stuart Washington, Glenn-Milo Santos, Jason Euren, Judith Martin, Alice Gleghorn & Phillip O. Coffin. (2018) Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study. Journal of Substance Abuse Treatment 85, pages 109-115.
Crossref
Crossref
Sunil Sirohi, Jane V. Aldrich & Brendan M. Walker. (2016) Species differences in the effects of the κ-opioid receptor antagonist zyklophin. Alcohol 51, pages 43-49.
Crossref
Crossref
Sarah G. Helton & Falk W. Lohoff. (2015) Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry Research 230:2, pages 121-129.
Crossref
Crossref
Christine M. Wilder & Theresa Winhusen. (2015) Pharmacological Management of Opioid Use Disorder in Pregnant Women. CNS Drugs 29:8, pages 625-636.
Crossref
Crossref
Jinhee Lee, Thomas F. Kresina, Melinda Campopiano, Robert Lubran & H. Westley Clark. (2015) Use of Pharmacotherapies in the Treatment of Alcohol Use Disorders and Opioid Dependence in Primary Care. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Wang Xuyi, Wang Juelu, Xiang Xiaojun, Li Haiyan, Liu Zheyuan, Gong Zhehui, Dong Guoming, Liu Gang, Li Jin & Hao Wei. (2014) Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence. The American Journal on Addictions 23:2, pages 162-169.
Crossref
Crossref
Javier A. Cepeda & Sandra A. Springer. 2014. Encyclopedia of Criminology and Criminal Justice. Encyclopedia of Criminology and Criminal Justice
1147
1159
.
Timothy W. Fong. 2013. Clinical Handbook of Adolescent Addiction. Clinical Handbook of Adolescent Addiction
311
320
.
Mary Beth DeYoungLeigh MacConellViren SarinMichael TrautmannPaul Herbert. (2011)
Encapsulation of Exenatide in Poly-(
d,l
-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
. Diabetes Technology & Therapeutics 13:11, pages 1145-1154.
Crossref
Crossref
Jay Prakash Jain, Wubeante Yenet Ayen, Abraham J. Domb & Neeraj Kumar. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development
1
58
.
David R. Gastfriend. (2011) Intramuscular extended-release naltrexone: current evidence. Annals of the New York Academy of Sciences 1216:1, pages 144-166.
Crossref
Crossref